The FDA has again issued a CRL to Aldeyra regarding the New Drug Application for reproxalap for the treatment of dry eye disease.

The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.

Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ocular health.

As we approach World Health Day (Monday 7 April), it’s an ideal opportunity to turn inwards and check on our own health and wellbeing. But did you know the incredible role that eyes play in supporting ...

The U.S. Food and Drug Administration has once again declined to approve Aldeyra Therapeutics treatment for dry eye disease, ...

Almost 7 in 10 Brits (67%) experience stress every week, according to new national research conducted ahead of Stress ...

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

We don’t know who first said that the eye is the window to the soul, but if they were around today, they might well phrase it ...

Learn to spot early warning signs from your eyes that may signal serious health issues and protect your vision before it's ...

In fact, “most patients (achieve) their desired vision within the first week following treatment,” said Dr Chai. While severe complications are rare, Dr Chai highlighted that side effects like dry ...

"This happens to every single astronaut, even those who go into space just for a few days," he said. Fluid shifts and vision problems: In space, bodily fluids move toward the head, increasing calcium ...